Lupin Ltd Unclassified
FDA Approved Drugs

Lupin Ltd Unclassified

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Unclassified
  • Total Records 46
  • Latest Approval Date -
  • Data Source FDA
  • First Approval Date -
All
584
View
Unclassified
46
View
Discontinued
204
View
OTC
1
View
RX
333
View
Company Overview

Company

Lupin Ltd Unclassified

Country

India

Social Profiles

LinkedIn
Company Snapshot

Lupin Ltd Unclassified

Kalina, Santacruz East, Mumbai 400 098

India

www.lupin.com/ info@lupin.com View on Map
FDA Approved Drug Records ( 46 records )
-
Unclassified Application: 218383

Drug Name

ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

-

218383 / 1

Active Ingredient

ABACAVIR;DOLUTEGRAVIR;LAMIVUDINE

Application Number

218383

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218383

Drug Name

ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE

Product Number

2

Dosage Form

-

Strength

30MG

Approval Date

-

218383 / 2

Active Ingredient

ABACAVIR;DOLUTEGRAVIR;LAMIVUDINE

Application Number

218383

Product Number

2

Dosage Form

-

Strength

30MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218383

Drug Name

ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE

Product Number

3

Dosage Form

-

Strength

60MG

Approval Date

-

218383 / 3

Active Ingredient

ABACAVIR;DOLUTEGRAVIR;LAMIVUDINE

Application Number

218383

Product Number

3

Dosage Form

-

Strength

60MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761212

Drug Name

ARMLUPEG

Product Number

1

Dosage Form

-

Strength

6MG/0.6ML

Approval Date

-

761212 / 1

Active Ingredient

PEGFILGRASTIM-UNNE

Application Number

761212

Product Number

1

Dosage Form

-

Strength

6MG/0.6ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 200751

Drug Name

ARMODAFINIL

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

-

200751 / 2

Active Ingredient

ARMODAFINIL

Application Number

200751

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 206529

Drug Name

BALSALAZIDE DISODIUM

Product Number

1

Dosage Form

-

Strength

1.1GM

Approval Date

-

206529 / 1

Active Ingredient

BALSALAZIDE DISODIUM

Application Number

206529

Product Number

1

Dosage Form

-

Strength

1.1GM

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 211532

Drug Name

DAPAGLIFLOZIN AND SAXAGLIPTIN MONOHYDRATE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

-

211532 / 1

Active Ingredient

DAPAGLIFLOZIN, SAXAGLIPTIN MONOHYDRATE

Application Number

211532

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 211532

Drug Name

DAPAGLIFLOZIN AND SAXAGLIPTIN MONOHYDRATE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

-

211532 / 2

Active Ingredient

DAPAGLIFLOZIN, SAXAGLIPTIN MONOHYDRATE

Application Number

211532

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202073

Drug Name

DARUNAVIR

Product Number

3

Dosage Form

-

Strength

300MG

Approval Date

-

202073 / 3

Active Ingredient

DARUNAVIR

Application Number

202073

Product Number

3

Dosage Form

-

Strength

300MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202073

Drug Name

DARUNAVIR

Product Number

4

Dosage Form

-

Strength

400MG

Approval Date

-

202073 / 4

Active Ingredient

DARUNAVIR

Application Number

202073

Product Number

4

Dosage Form

-

Strength

400MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202073

Drug Name

DARUNAVIR

Product Number

5

Dosage Form

-

Strength

600MG

Approval Date

-

202073 / 5

Active Ingredient

DARUNAVIR

Application Number

202073

Product Number

5

Dosage Form

-

Strength

600MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 202073

Drug Name

DARUNAVIR

Product Number

6

Dosage Form

-

Strength

800MG

Approval Date

-

202073 / 6

Active Ingredient

DARUNAVIR

Application Number

202073

Product Number

6

Dosage Form

-

Strength

800MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 207393

Drug Name

DICLOFENAC

Product Number

1

Dosage Form

-

Strength

18MG

Approval Date

-

207393 / 1

Active Ingredient

DICLOFENAC

Application Number

207393

Product Number

1

Dosage Form

-

Strength

18MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 207393

Drug Name

DICLOFENAC

Product Number

2

Dosage Form

-

Strength

35MG

Approval Date

-

207393 / 2

Active Ingredient

DICLOFENAC

Application Number

207393

Product Number

2

Dosage Form

-

Strength

35MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 214544

Drug Name

DOLUTEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE

Product Number

1

Dosage Form

-

Strength

50MG;200MG;25MG

Approval Date

-

214544 / 1

Active Ingredient

DOLUTEGRAVIR;EMTRICITABINE;TENOFOVIR ALAFENAMIDE

Application Number

214544

Product Number

1

Dosage Form

-

Strength

50MG;200MG;25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 213120

Drug Name

DOLUTEGRAVIR; RILPIVIRINE

Product Number

1

Dosage Form

-

Strength

50MG/25MG

Approval Date

-

213120 / 1

Active Ingredient

DOLUTEGRAVIR;RILPIVIRINE

Application Number

213120

Product Number

1

Dosage Form

-

Strength

50MG/25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 91277

Drug Name

DOXYCYCLINE

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

-

91277 / 1

Active Ingredient

DOXYCYCLINE

Application Number

91277

Product Number

1

Dosage Form

-

Strength

40MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 216936

Drug Name

DROSPIRENONE

Product Number

1

Dosage Form

-

Strength

4MG

Approval Date

-

216936 / 1

Active Ingredient

DROSPIRENONE

Application Number

216936

Product Number

1

Dosage Form

-

Strength

4MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 213654

Drug Name

EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG; 1GM

Approval Date

-

213654 / 1

Active Ingredient

EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE

Application Number

213654

Product Number

1

Dosage Form

-

Strength

5MG; 1GM

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 213654

Drug Name

EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

10MG; 1GM

Approval Date

-

213654 / 2

Active Ingredient

EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE

Application Number

213654

Product Number

2

Dosage Form

-

Strength

10MG; 1GM

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 213654

Drug Name

EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

12.5MG; 1GM

Approval Date

-

213654 / 3

Active Ingredient

EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE

Application Number

213654

Product Number

3

Dosage Form

-

Strength

12.5MG; 1GM

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 213654

Drug Name

EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

25MG; 1GM

Approval Date

-

213654 / 4

Active Ingredient

EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE

Application Number

213654

Product Number

4

Dosage Form

-

Strength

25MG; 1GM

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 215071

Drug Name

EMTRICITABINE; TENOFOVIR ALAFENAMIDE

Product Number

1

Dosage Form

-

Strength

200MG;25MG

Approval Date

-

215071 / 1

Active Ingredient

EMTRICITABINE;TENOFOVIR ALAFENAMIDE

Application Number

215071

Product Number

1

Dosage Form

-

Strength

200MG;25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 204130

Drug Name

FOSAMPRENAVIR CALCIUM

Product Number

1

Dosage Form

-

Strength

700MG

Approval Date

-

204130 / 1

Active Ingredient

FOSAMPRENAVIR CALCIUM

Application Number

204130

Product Number

1

Dosage Form

-

Strength

700MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 216074

Drug Name

IVACAFTOR

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

-

216074 / 1

Active Ingredient

IVACAFTOR

Application Number

216074

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 217431

Drug Name

IVACAFTOR

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

-

217431 / 2

Active Ingredient

IVACAFTOR

Application Number

217431

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 217431

Drug Name

IVACAFTOR

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

-

217431 / 3

Active Ingredient

IVACAFTOR

Application Number

217431

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 217431

Drug Name

IVACAFTOR

Product Number

4

Dosage Form

-

Strength

75MG

Approval Date

-

217431 / 4

Active Ingredient

IVACAFTOR

Application Number

217431

Product Number

4

Dosage Form

-

Strength

75MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 91328

Drug Name

LEVONORGESTREL

Product Number

2

Dosage Form

-

Strength

0.75MG

Approval Date

-

91328 / 2

Active Ingredient

LEVONORGESTREL

Application Number

91328

Product Number

2

Dosage Form

-

Strength

0.75MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 203113

Drug Name

LO-BLISOVI FE

Product Number

1

Dosage Form

-

Strength

1MG;0.01MG;75MG

Approval Date

-

203113 / 1

Active Ingredient

NORETHINDRONE ACETATE;ETHINYL ESTRADIOL;FERROUS FUMARATE

Application Number

203113

Product Number

1

Dosage Form

-

Strength

1MG;0.01MG;75MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 205286

Drug Name

MILNACIPRAN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

-

205286 / 1

Active Ingredient

MILNACIPRAN HYDROCHLORIDE

Application Number

205286

Product Number

1

Dosage Form

-

Strength

12.5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 205286

Drug Name

MILNACIPRAN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

-

205286 / 2

Active Ingredient

MILNACIPRAN HYDROCHLORIDE

Application Number

205286

Product Number

2

Dosage Form

-

Strength

25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 205286

Drug Name

MILNACIPRAN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

-

205286 / 3

Active Ingredient

MILNACIPRAN HYDROCHLORIDE

Application Number

205286

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 205286

Drug Name

MILNACIPRAN HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

-

205286 / 4

Active Ingredient

MILNACIPRAN HYDROCHLORIDE

Application Number

205286

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219404

Drug Name

OXCARBAZEPINE EXTENDED RELEASE TABLETS

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

-

219404 / 2

Active Ingredient

OXCARBAZEPINE

Application Number

219404

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219404

Drug Name

OXCARBAZEPINE EXTENDED RELEASE TABLETS

Product Number

3

Dosage Form

-

Strength

600MG

Approval Date

-

219404 / 3

Active Ingredient

OXCARBAZEPINE

Application Number

219404

Product Number

3

Dosage Form

-

Strength

600MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218846

Drug Name

PITOLISANT HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 4.45MG BASE

Approval Date

-

218846 / 1

Active Ingredient

PITOLISANT HYDROCHLORIDE

Application Number

218846

Product Number

1

Dosage Form

-

Strength

EQ 4.45MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218846

Drug Name

PITOLISANT HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 17.8MG BASE

Approval Date

-

218846 / 2

Active Ingredient

PITOLISANT HYDROCHLORIDE

Application Number

218846

Product Number

2

Dosage Form

-

Strength

EQ 17.8MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 201989

Drug Name

PREGABALIN

Product Number

1

Dosage Form

-

Strength

20MG/ML

Approval Date

-

201989 / 1

Active Ingredient

PREGABALIN

Application Number

201989

Product Number

1

Dosage Form

-

Strength

20MG/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761480

Drug Name

RANLUSPEC

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

-

761480 / 1

Active Ingredient

RANIBIZUMAB-HKDZ

Application Number

761480

Product Number

1

Dosage Form

-

Strength

10MG/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761480

Drug Name

RANLUSPEC

Product Number

2

Dosage Form

-

Strength

6MG/ML

Approval Date

-

761480 / 2

Active Ingredient

RANIBIZUMAB-HKDZ

Application Number

761480

Product Number

2

Dosage Form

-

Strength

6MG/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 204402

Drug Name

TENOFOVIR DISOPROXIL FUMARATE

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

-

204402 / 1

Active Ingredient

TENOFOVIR DISOPROXIL FUMARATE

Application Number

204402

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 204402

Drug Name

TENOFOVIR DISOPROXIL FUMARATE

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

-

204402 / 2

Active Ingredient

TENOFOVIR DISOPROXIL FUMARATE

Application Number

204402

Product Number

2

Dosage Form

-

Strength

200MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 204402

Drug Name

TENOFOVIR DISOPROXIL FUMARATE

Product Number

3

Dosage Form

-

Strength

250MG

Approval Date

-

204402 / 3

Active Ingredient

TENOFOVIR DISOPROXIL FUMARATE

Application Number

204402

Product Number

3

Dosage Form

-

Strength

250MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 204402

Drug Name

TENOFOVIR DISOPROXIL FUMARATE

Product Number

4

Dosage Form

-

Strength

300MG

Approval Date

-

204402 / 4

Active Ingredient

TENOFOVIR DISOPROXIL FUMARATE

Application Number

204402

Product Number

4

Dosage Form

-

Strength

300MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 216064

Drug Name

VALBENAZINE TOSYLATE

Product Number

3

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

-

216064 / 3

Active Ingredient

VALBENAZINE TOSYLATE

Application Number

216064

Product Number

3

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

-

Regulatory Status

Unclassified

Related Databases
  • FDA Inspections
    49 View
  • EDQM CEP
    31 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    13 View
  • FDA Approved Drugs Database
    584 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
46 total
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE

Application Number

218383

Product Number

1

Active Ingredient

ABACAVIR;DOLUTEGRAVIR;LAMIVUDINE

Dosage Form

-

Strength

5MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.